| 15.23 Real-Time Quote | -0.17 / -1.10%Today’s Change | 4.36 Today|||52-Week Range 16.48 | +126.97% Year-to-Date |
| A Trio of Cancer Immunotherapy Innovators Jun 14 / MotleyFool.com | The Poor Action Continues Jun 12 / TheStreet.com |
| Good And Bad Breast Cancer Drugs Jun 14 / MotleyFool.com | More Signs of a Change Jun 12 / TheStreet.com |
| Feels Like a Bear Market Jun 12 / TheStreet.com | A Promising Platform for Cancer Immunotherapy Jun 10 / MotleyFool.com |